Juul Quietly Revamped Its E-Cigarette, Risking the FDA’s Rebuke
The company made changes to the world’s bestselling e-cigarette that might draw unwelcome attention from regulators.
Related Articles
Early tests of H5N1 prevalence in milk suggest U.S. bird flu outbreak in cows is widespread
The prevalence of H5N1 genetic material in purchased milk products suggests the bird flu outbreak is far more widespread in cows than official counts indicate.
Bolstering FDA Pathways for Reducing Death and Disease from Tobacco
This JAMA Forum discusses the US Food and Drug Administration’s efforts to implement the 2009 Family Smoking Prevention and Tobacco Control Act through approval of…
Family Unfriendly: How Our Culture Made Raising Kids Much Harder Than It Needs to Be
Family Unfriendly: How Our Culture Made Raising Kids Much Harder Than It Needs to Be
House Republicans press FDA to expedite approval process for smoke-free tobacco products – Washington Examiner
A group of nearly 70 House Republicans led by Rep. Richard Hudson (R-NC) pressed the president to move forward with long-pending applications for new smoke-free…
The Conservative Futurist: How to Create the Sci-Fi World We Were Promised
The Conservative Futurist: How to Create the Sci-Fi World We Were Promised
FDA Issues Long-Awaited Proposed Rule To Regulate Laboratory-Developed Tests | Insights | Skadden, Arps, Slate, Meagher & Flom LLP
On September 29, 2023, FDA issued its much-anticipated proposed rule to regulate laboratory-developed tests as medical devices. If enacted as proposed, the rule will have…
Accelerated approval will be ‘the norm’ for gene therapies, FDA’s Peter Marks says
The FDA will increasingly use accelerated approval for gene therapies aimed at rare conditions, according to Peter Marks, the FDA’s top official overseeing cell and…
Accelerated approval will be ‘the norm’ for gene therapies, FDA’s Peter Marks says
The FDA will increasingly use accelerated approval for gene therapies aimed at rare conditions, according to Peter Marks, the FDA’s top official overseeing cell and…
Accelerated approval will be ‘the norm’ for gene therapies, FDA’s Peter Marks says
The FDA will increasingly use accelerated approval for gene therapies aimed at rare conditions, according to Peter Marks, the FDA’s top official overseeing cell and…
Opinion: Nicotine pouches help smokers quit. Don’t ban them
Nicotine in cigarettes doesn’t kill you, tobacco does. Nicotine pouches do not contain tobacco, so they don’t need close regulation. Read on